Novel treatment strategy shows promise against common liver cancer in children

Hepatoblastoma (HB) is the most common liver cancer in children. Researchers and physicians in the field are concerned because in the last decade HB has been rising rapidly worldwide and has seen the most rapid increase among all pediatric solid tumors.

Related Keywords

Texas ,United States ,Baylor College Of Medicine ,Roma ,Lazio ,Italy ,Andras Heczey ,Ashley Duong ,Andrewa Badachhape ,Kalyanir Patel ,Karl Dimiter Bissig ,Michaelt Lewis ,Pavel Sumazin ,Rohitk Srivastava ,Ramakrishnanr Srinivasan ,Sanjeeva Vasudevan ,Charles Keller ,Martin Urbicain ,Richard Whitlock ,Pavan Kureti ,Xinjian Yu ,Laceye Dobrolecki ,Dina Kats ,Sarahe Woodfield ,Saiabhiroopr Govindu ,Mohammadj Najaf ,Bryan Armbruster ,Barry Zorman ,Stephenf Sarabia ,Macy Easom Cancer Research Foundation Grant ,Cancer Center Support Grant ,Baylor Michaele Debakey Department Of Surgery ,Research Institute Of Texas ,Investigator Research Award ,Baylor College ,Bakey Department ,Abhishek Kona ,Angela Major ,Texas Children ,Cancer Therapy Development Institute ,Defense Career Development Award ,Medicine Michael ,Surgery Faculty Research Award ,Cancer Prevention ,Research Institute ,Multi Investigator Research Award ,Center Support Grant ,Facilities Support Grant ,Hepatoblastoma ,Dancer ,Children ,Nzyme ,Hepatology ,Irinotecan ,Liver ,Liver Cancer ,Medicine ,Ortality ,Reclinical ,Research ,Surgery ,Humor ,Vincristine ,